技術指標
指標
數值
方向
MACD(12,26,9)
-0.061
賣出
RSI(14)
31.765
中性
STOCH(KDJ)(9,3,3)
18.235
中性
ATR(14)
0.126
低波動
CCI(14)
-136.413
賣出
Williams %R
94.643
超賣
TRIX(12,20)
-0.728
賣出
StochRSI(14)
0.000
賣出
搜尋
Cardio Diagnostics Holdings Inc
CDIO添加自選
1.550USD
-0.050-3.13%
收盤 07-24 16:00（美東）報價延遲15分鐘
4.59M總市值
0.06本益比TTM
關鍵數據
1.630今開
1.645最高
1.24M成交量
0.06本益比TTM
--本益比動
--股利TTM
41.83%換手率
1.630昨收
1.520最低
1.08M成交額
虧損本益比靜
0.52市淨率
0.00%股息率 TTM
-60.90%ROA
7.91052週最高
4.63量比
-8.38M淨利潤
2.96M總股本
24.7603每股盈餘TTM
2.20Beta
-65.59%ROE
0.97052週最低
7.67%振幅
100.00%毛利率
4.59M總市值
-2.17回報/風險
8.73%風險率
TradingKey Cardio Diagnostics Holdings Inc股票評分
單位: USD 更新時間: 2026-07-24操作建議
Cardio Diagnostics Holdings Inc當前公司基本面數據相對非常健康，增長潛力很大。當前估值合理，在生物技術與醫療研究行業排名202/386位。機構持股佔比非常高，近一月多位分析師給出公司評級為。最高目標價為60.00。中期看，股價處於下降通道。近一個月，市場表現非常差，但基本面評分較高。目前股價在壓力位和支撐位之間，可以做區間波段操作。
Cardio Diagnostics Holdings Inc評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
公司輿情
過去24小時
熱度
過冷
過熱
看好
Cardio Diagnostics Holdings Inc亮點
亮點風險
Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development, and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.
業績增長期
公司處於發展階段，最新年度總收入14.82K美元
估值高估
公司最新PE估值0.06，處於3年歷史高位
機構減倉
最新機構持股138.49K股，環比減少14.75%
詹姆斯·西蒙斯持倉
明星投資者詹姆斯·西蒙斯持倉，最新持倉17.10K股
分析師目標
基於
0
分析師
--
評級
60.000
目標均價
+1227.43%
漲幅空間
Cardio Diagnostics Holdings Inc新聞
即將為您帶來更多新聞，敬請期待。 。 。
收益預測
分析師評級
基於
0
分析師
--
評級
60.000
目標均價
+1227.43%
漲幅空間
強力買入
買入
持有
賣出
強力賣出
同行比較
496
總數
6
中位數
7
平均值
公司名稱
評級分佈
分析師數
Cardio Diagnostics Holdings Inc
CDIO
0
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
IQVIA Holdings Inc
IQV
26
argenx SE
ARGX
26
Insmed Inc
INSM
23
1
2
3
...
99
技術指標
移動平均線
指標
數值
方向
MA5
1.632
賣出
MA10
1.695
賣出
MA20
1.841
賣出
MA50
1.860
賣出
MA100
2.161
賣出
MA200
2.613
賣出
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
Cardio Diagnostics Holdings Inc簡介
Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development, and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.
公司代碼CDIO
公司Cardio Diagnostics Holdings Inc
CEODogan (Meeshanthini V)
網址
公司股東
相關品種
+0.88%
+1.60%
+0.43%
+0.90%
+0.46%
-0.72%
+1.22%
+1.25%
-1.18%
-0.12%
+0.94%
+0.90%
+1.20%
-0.02%
+2.04%
0.00%
+0.63%
-0.69%
+2.59%
+0.89%熱門品種
51900.000
+176.000 (+0.34%)
28150.400
-427.600 (-1.50%)
7408.100
-11.800 (-0.16%)
14948.000
-153.000 (-1.01%)
64219.000
-1152.000 (-1.76%)
6264.500
+48.800 (+0.79%)
90.043
-2.069 (-2.25%)
333.020
+11.360 (+3.53%)
206.840
-1.920 (-0.92%)
4052.350
+2.980 (+0.07%)
常見問題
Cardio Diagnostics Holdings Inc(CDIO)的當前股價是多少？
Cardio Diagnostics Holdings Inc(CDIO)的當前股價是 1.55。
Cardio Diagnostics Holdings Inc 的股票代碼是什麼？
Cardio Diagnostics Holdings Inc的股票代碼是CDIO。
Cardio Diagnostics Holdings Inc股票的52週最高點是多少？
Cardio Diagnostics Holdings Inc股票的52週最高點是7.91。
Cardio Diagnostics Holdings Inc股票的52週最低點是多少？
Cardio Diagnostics Holdings Inc股票的52週最低點是0.97。
Cardio Diagnostics Holdings Inc的市值是多少？
Cardio Diagnostics Holdings Inc的市值是4.59M。
Cardio Diagnostics Holdings Inc(CDIO)股票的每股收益（EPS TTM）是多少
Cardio Diagnostics Holdings Inc(CDIO)股票的每股收益（EPS TTM）是-3.71。